Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy

Despite the good responses of patients (pts) with stage III breast cancer to neoadjuvant chemotherapy (NAC), most eventually relapse and have a poor prognosis. We investigated the prognostic indicators in pts with stage III breast cancer treated with NAC, using epirubicin and/or docetaxel. A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: TAKAHASHI, RYUJI, TOH, UHI, IWAKUMA, NOBUTAKA, MISHIMA, MAI, FUJII, TERUHIKO, TAKENAKA, MIKI, KOURA, KEIKO, SEKI, NAOKO, KAWAHARA, AKIHIKO, KAGE, MASHAYOSHI, OGO, ETSUYO, SHIROUZU, KAZUO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820806/
https://www.ncbi.nlm.nih.gov/pubmed/24223627
http://dx.doi.org/10.3892/etm.2013.1289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820806/
https://www.ncbi.nlm.nih.gov/pubmed/24223627
http://dx.doi.org/10.3892/etm.2013.1289

Ejemplares similares